Phase I, open-label, multicentre, dose-escalation,...

Phase I, open-label, multicentre, dose-escalation, pharmacokinetic and pharmacodynamic trial of the oral aurora kinase inhibitor PF-03814735 in advanced solid tumours

Patrick Schöffski, Suzanne F. Jones, Herlinde Dumez, Jeffrey R. Infante, Elke Van Mieghem, Camilla Fowst, Paola Gerletti, Huiping Xu, John L. Jakubczak, Patricia A. English, Kristen J. Pierce, Howard
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
47
Year:
2011
Language:
english
Pages:
2265
DOI:
10.1016/j.ejca.2011.07.008
File:
PDF, 215 KB
english, 2011
Conversion to is in progress
Conversion to is failed